A Product of
This information is intended for patients and caregivers only. It is not a substitute for professional medical advice, diagnosis, or treatment. The content on this page is for informational purposes only and should not be used to make decisions about your health or medical care.
By continuing, I acknowledge reading and understanding this disclaimer.
RenehaVis™ dosage regimen is injection into the affected synovial joint space once a week for up to three injections depending on the severity of the degenerative change to the synovial joint. The duration of effect in patients with grade 1 to 3 medial compartment osteoarthritis of the knee joint has been demonstrated to be up to twelve months.
RenehaVis™ should always be administered by a trained medical professional and is given intra-articularly to either the knee joint, into the knee synovial capsule (note: also known as the joint cavity), or the hip, into the hip capsule. It is a patented syringe with dual chambers, each containing different Hyaluronic Acids (HA) administered sequentially.
RenehaVis™ reduces pain Faster and Better clinically proven in knee study. A clinical study demonstrated that RenehaVis™ reduced pain during rest and weight bearing in a shorter period than other hyaluronic acids (HA) of either high or low molecular weight.
RenehaVis™ helps to increase both the lubrication and shock absorbency in the knee and hip joint.
RenehaVis™ helps also to stimulate the endogenous production of natural hyaluronic acid (HA) within the knee and hip joint.
RenehaVis™ effects may last up to at least 12 months after a full treatment.
Enhances joint lubrication in the knee and hip.
Enhances shock absorption in the knee and hip
12+ months of relief after a full treatment.
Natural HA